28Feb/22

Nat Commun: Natural env Trimer Produces Tier-2 Neutralizing Antibodies Against HIV In Vivo

February 28, 2022Popular Vaccine, Vaccine News, Vaccine ResearchHIV vaccine, Neutralizing Antibodies, Tier-2biovaccine

Nearly 40 years after the discovery of HIV, it has killed 36.3 million people, but so far there is still no effective vaccine available. In a new study, however, researchers from theRead More…

18Jan/22

New strategy for vaccine development! Memory helper T cells perpetuate memory B cells that resist chronic viral infection

January 18, 2022Vaccine News, Vaccine Researchhcv vaccine, vaccine designbiovaccine

Viruses such as HIV or hepatitis C virus (HCV) can destroy the immune system. So far, one way to develop vaccines against these chronic infections is to target memory B cells, aRead More…

23Dec/21

Improve tumor vaccination using farnesylthiosalicylic acid derivative PEI nanocomposite

December 23, 2021Vaccine Researchcancer vaccine, tumor vaccination, vaccine delivery systembiovaccine

Tumor vaccine is a promising therapeutic strategy, which produces long-term anti-tumor immunity by stimulating immune responses accordingly. However, due to inefficient vaccination, the clinical efficacy of such vaccines is limited. Recently, inRead More…

16Nov/21

World’s first clinical trial of breast cancer vaccine launched

November 16, 2021Vaccine Researchbreast cancer vaccine, vaccine developmentbiovaccine

Researchers at the Cleveland Clinic in the United States launched a new vaccine study aimed at eventually preventing triple negative breast cancer, a highly invasive and deadly form of cancer. The vaccineRead More…

21Oct/21

Breakthrough: Broad-spectrum Anti-infective Vaccine to Solve Microbial Drug Resistance

October 21, 2021Vaccine NewsBacterial vaccine, recombinant vaccinesbiovaccine

With the mounting number of drug-resistant microbial infections, the epidemic outbreak of pathogenic bacteria, and the possible threat of new organisms in the future, the clinical intervention of infectious diseases is facingRead More…

14Sep/21

Nature Communication: Cancer vaccine may effectively overcome the drug tolerance of cancer cells

September 14, 2021Popular Vaccine, Vaccine News, Vaccine Researchcancer vaccine, tumor vaccinebiovaccine

In the clinical trial of oncolytic vesicular stomatitis virus expressing interferon-β (VSV-IFN-β), a large group of patients initially achieved a preliminary response, but then the disease relapsed. A few days ago, inRead More…

17Aug/21

Science sub-journal: vaccination of symbiotic bacteria expressing NadA can prevent meningitis caused by Neisseria meningitidis

August 17, 2021Vaccine Researchmeningitis, Neisseria meningitidisbiovaccine

In a recent study, researchers from the University of Southampton in the UK inserted a gene into a harmless bacteria that allowed it to stay in the nose for a long timeRead More…

27Jul/21

What is mRNA vaccine?

July 27, 2021Popular VaccinemRNA Vaccine, non-replicating mRNA, self-amplifying mRNAbiovaccine

mRNA vaccine is to transfer RNA to the cells of the body to express and produce protein antigens, so as to induce the body to produce an immune response against the antigen,Read More…

13Jul/21

News of HIV Medication: Oxford Innitiated the Clinical Trial of HIVconsvX Vaccine

July 13, 2021Vaccine News, Vaccine ResearchHIV vaccinebiovaccine

Recently, the University of Oxford in the United Kingdom started a first phase clinical trial of a new HIV vaccine candidate in the United Kingdom. The trial, called HIV-CORE 0052, aims toRead More…

07Jul/21

Nature: The protective effect of mRNA vaccine BNT162b2 against COVID-19 variant may be weakened

July 7, 2021Vaccine ResearchCOVID-19 variant, mRNA Vaccine, Naturebiovaccine

At present, a large-scale vaccination of COVID-19 is carrying out around the world, bringing hope for alleviating the epidemic situation of COVID-19’s. However, due to the menacing invasion of various SARS-CoV-2 variantsRead More…